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Bovine heart mitochondrial coupling factor B was isolated and purified to homogeneity in its active form. The amino-terminal amino acid sequence 
of the alkylated protein was determined. Two chains with exactly the same sequence except for the presence of an additional Phe at the amino- 
terminus on one of them were obtained. The 55 amino acid sequence appears to be largely hydrophilic with several charged amino acid residues. 
This sequence showed no homology with the E. coli unc operon, oligomycin sensitivity conferring protein, or coupling factor 6 or any protein 
in the data base. 
1. INTRODUCTION 
Bovine heart mitochondrial ATP synthase 
(H + -ATPase or FI-F,) is an inner membrane multipro- 
tein complex, concerned with the terminal reactions of 
oxidative phosphorylation leading to the synthesis of 
ATP. It is composed of two separable structures: Fi is 
soluble, hydrophilic, comprises of 5 subunits and is 
directly involved in the hydrolysis of ATP; F,, the 
membrane sector, is hydrophobic and is involved in H + 
conduction. While Fi is preparations obtained from 
different sources exhibit certain similarities with respect 
to the number, size, function and primary structure of 
the subunits, the F, appears to show large variations 
from one source to another. The E. coli F, is composed 
of only three subunits, named a, b and c [l-3], and that 
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of bovine heart is known to contain additional subunits 
including oligomycin sensitivity conferring protein 
(OSCP), coupling factor 6 (Fb), coupling factor B (FB) 
and other poorly defined subunits [4]. The SDS gel elec- 
trophoresis patterns of most of the purified bovine 
heart mitochondrial F, preparations thus show the 
presence of more than 4 proteins. 
Coupling factor B has been shown to be a functional 
component of bovine heart mitochondrial H + -ATPase 
required for Pi-ATP exchange in FB-depleted sub- 
mitochondrial particles but not for oligomycin-sensitive 
ATPase [5,6]. Subsequent work involving depletion- 
reconstitution and inhibition by Cd2 + established FB as 
an essential component of F, necessary for H + conduc- 
tion [7,9]. Enzyme-linked immunosolvent assay using 
monoclonal antibody to Fn has also revealed Fg 
presence in F,-Fi in amounts stoichiometric with Fi 
[lo]. This report deals with the recently obtained infor- 
mation on the NHz-terminal amino acid sequence of 
this protein. 
2. EXPERIMENTAL 
Mitochondria were prepared as described earlier [9] and the 
ammonia-EDTA particles by a modification of the procedure describ- 
ed earlier [I I]. 
3. RESULTS 
3.1. Preparation of alkylated FB and sequence analysis 
The purification and assay of Fn were carried out 
essentially as described earlier [I 1,121 except for the 
following changes. The functionally active fractions 
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from the DEAE-cellulose column chromatography 
were pooled, concentrated by ultrafiltration through a 
PM-30 membrane (Amicon). The pH of the concen- 
trated fractions was adjusted to 5.3 by adding 6 M 
acetic acid when the solution became cloudy. It was 
allowed to stand on ice for 30 min and centrifuged 
twice, each time for 10 min at 19 000 x g in SS-34 Sor- 
vall rotor, in order to remove the precipitated proteins. 
The pH of the clear supernatant was adjusted back to 
7.0 using 1 M Tris base. Almost 90% of the activity was 
recovered in the supernatant. For the CM-cellulose 
chromatography, the column was equilibrated with 20 
mM Hepes-KOH, pH 7.0; the Fa in Hepes buffer was 
brought to pH 7.5 and loaded on the column. The pH 
of 7.5 was used to avoid precipitation of Fa. The active 
protein was eluted from the column with 50 mM Hepes- 
KOH, pH 7.0. Between different steps of purification, 
the Fa containing fractions were concentrated by 
ultrafiltration through Amicon PM-30, and the activity 
was stabilized (for storage) by the addition of DTT and 
glycerol to 20 mM and 5-8070, respectively. 
Maintenence of a minimum concentration of 200 mM 
Tris-Cl, pH 7.5, was found to minimize the loss in ac- 
tivity of the concentrated preparations. The final 
purification step was carried out on a Sephadex G-75 
column [l 11. A typical fractionation pattern of the ac- 
tivity correlated with the protein staining of the in- 
dividual fractions is shown in Fig. 1. 
Fractions of Fa with the highest activity (Fig. 1) from 
two separate Sephadex G-75 column chromatography 
runs, i.e. from the last stage of purification containing 
a total of 160 units were pooled and lyophilized to 
reduce the volume to about 3-4 ml. The concentrated 
sample was dialysed against buffer containing 10 mM 
Tris-Cl, pH 7.5, 2% methanol and 0.1% 
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2-mercaptoethanol and later against water containing 
the above concentrations of methanol and 
2-mercaptoethanol but no buffer. The dialysed sample 
was concentrated by centrifugation under vacuum and 
to this was added 100 ~1 of 7 M guanidine hydrochloride 
containing 0.5 M Tris-Cl, pH 8.5, and 14 mM 
2-mercaptoethanol. The solution was incubated at 30°C 
for 1.5 h, then 1 ~1 of 4-vinylpyridine added and in- 
cubated at room temperature for 3 h. Then 5 ~1 of 5 M 
DTT was added, and the solution was incubated for 30 
min at room temperature. Finally, the sample was 
dialysed against water, when the protein precipitated 
and it was transferred to a glass tube using a Pasteur 
pipette. A small aliquot of this uniform suspension of 
the precipitate was analyzed by polyacrylamide gel elec- 
trophoresis (PAGE) [13] and silver staining [14]. As 
shown in Fig. 2, a prominent band at about 22 kDa was 
seen with negligible contamination. The suspension was 
centrifuged at 2000 rpm for 20 min and the precipitate 
was washed twice with water. The water adhering to the 
precipitate was removed by centrifugation under 
vacuum. The protein, 20 pg as estimated by analysis of 
the amino acid composition, was dissolved in 45% for- 
mic acid and analyzed for sequence using the Applied 
Biosystems Instruments, Model 470A Protein Se- 
quencer, equipped with an on-line HPLC system (ABS 
120 A PTH analyzer) using a reverse phase Crs 
(Brownlee) column. The Edman degradation was car- 
ried out to 55 cyles without any problem in detecting the 
amino acids. The initial yield was about 50% and the 
repetitive yield was > 92%. It was clear from the data 
that two proteins which differed only by the presence of 
one phenylalanine at the NH*-terminal were sequenced 
simultaneously (Fig. 3). The initial recovery of Phe was 
661 pmol and of Trp 356 pmol. Except for the first Phe, 
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Fig. 1. Purification of Fa by Sephadex G-75 column chromatography: analysis by PAGE followed by silver staining of the active fractions. 
Sephadex G-75-40 column (2.5 x 75 cm) was equilibrated with buffer containing 50 mM Tris-Cl, pH 7.5, 1 mM EDTA, 1 mM DTT and 1% 
glycerol. Void volume of the column was 123 ml. The concentrated fraction from the CM-cellulose chromatography, 2.4 ml containing 85 units 
of activity, was loaded on the column. Fractions of 2.6 ml were collected. Most of the protein was recovered in the void volume with almost little 
or no Fa activity. The Fa activity was typically obtained at the end of the second void volume, i.e. at 220-240 ml with almost undetectably low 
protein levels. Left: 20 pl from each fraction was withdrawn and assayed for activity. Right: 50 pl from each fraction was lyophilized to dryness, 
and suspended in sample loading buffer and gel electrophoresis carried out under reducing conditions [7]. The gel was stained with silver [13,14]. 
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Fig. 2. Electrophoresis of purified Fa: approximately 160 units of 
purified Fa was alkylated, dialyzed and the precipitated Fa protein 
was washed in 0.5 ml of HzO. Lanes A, B and C correspond to 0.4, 
0.8 and 2.0 pl aliquots mized with the sample digestion mixture for 
PAGE and silver staining (13,141. The remaining sample was used for 
sequence analysis. The protein standards in lane 1 were trypsinogen 
and soy bean trypsin inhibitor. 
every amino acid appeared in two successive cycles. 
In another experiment, preparative PAGE of 
purified alkylated Fn using 1.5 mm thick gel with a large 
well comb was carried out. After the usual staining and 
destaining of the gel with Coomassie brilliant blue, the 
protein band was sliced and the protein was elec- 
troeluted [15]. The extracted protein was analyzed for 
the sequence (data not shown). In spite of poor extrac- 
tion of protein from the gel, 16 cycles were completed 
and the presence of two polypeptides with similar se- 
quence except for a Phe at the NHz-terminal on one of 
the chains was again evident. 
The ragged NHz-terminal ends were also noted for 
the ATPase inhibitor protein of bovine mitochondria 
[16] and the Q, p and y subunits of bovine Fi-ATPase 
[17]. The reason for occurrence of these frayed 
NHz-terminal ends is not understood; it has been sug- 
gested that non-uniform processing of the precursor 
proteins during transport into mitochondria may have 
occurred. A second explanation may be cleavage of the 
NHz-terminal residues from some of the chains by an 
aminopeptidase. 
3.2. Confirmation of FB amino acid sequence 
The hydropathy plot [18] for the 55 amino acid pep- 
tide revealed extensive hydrophilic character except for 
a small stretch of hydrophobicity in the first few 
Fig. 3. The partial protein sequence of Fe. The NHz-terminal se- 
quence began with Phe as residue number 1 for two-thirds of the pro- 
tein that was sequenced. The rest began with Trp as residue number 
1. There may be a slight uncertainty regarding the identity of the 
amino acids in [ 1. 
residues at the NH2-terminal end (data not shown). A 
strongly hydrophilic stretch of 13 amino acids, from 
11-23, was selected for peptide synthesis. This stretch 
represents a hydrophilic region with clustered acidic 
and basic amino acids. This peptide was commercially 
synthesized and conjugated to KLH and ovalbumin 
(Immuno-Dynamics, LaJolla, CA). For immunization, 
10 mg of each conjugated peptide was dissolved in 4 ml 
PBS and vortexed vigorously with 4 ml of complete 
Freund adjuvant until complete emulsification was 
achieved. The antigen (0.25 mg) was administered to 
each of the lo-week-old rabbits by intradermal injec- 
tion at 4 places on the back. Rabbit serum obtained 
after the immunogenic response was established, as 
determined by enzyme-linked immunosorbent assay 
(ELISA) [lo], was used at a dilution of 1:300 for 
Western blot [lo] of highly purified (Sephadex G-5 
step) Fa and partially purified Fn (CM-Sephadex frac- 
tion). Correspondence of bands detected by antibody 
reactivity with the previously reported monoclonal an- 
tibody to Fg (data not shown) established the presence 
of Fa-specific antibodies in the sera of rabbits immuniz- 
ed with the synthetic peptide. These data also support 
the validity of the amino acid sequence reported in Fig. 
3, at least with respect o amino aids 1 l-23. 
3.3. Search for homologous sequences 
The database for proteins and nucleic acids, and the 
computer programs for sequence analysis were obtain- 
ed through Bionet Services. The available FB amino 
acid sequence as well as its reverse translated DNA se- 
quence were used to align and search the complete pro- 
tein database, bovine sequences of Fn and E. coli unc 
operon. Direct comparison was made with the amino 
acid sequence of OSCP [19] and that of F6 [20]. None 
of the above revealed significant homology with the 
NH s-terminal sequence of FB. Fearnley and Walker 
[21] have claimed that the proteins encoded by 
mitochondrial genes A6L and ATPase 6 are bona fide 
components of ATP-synthase. They have also sequenc- 
ed subunit b (24 kDa) and a protein named ‘d’ of 
molecular mass 18 600 which co-purified with the com- 
plex. The involvement of the A6L gene product and 
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subunits ‘b’ and ‘d’ in ATP synthesis has not been 
demonstrated. The Fa sequence did not show any 
resemblance to these sequences. 
4. DISCUSSION 
F, preparations derived from ATP synthases of dif- 
ferent organisms have passive proton conductance ac- 
tivity. However, there are differences between them in 
subunit composition. The F, from prokaryotes has 
generally fewer protein subunits than F, from the 
mitochondria of eukaryotes. E. coli F,, which has been 
studied in the greatest detail, has three distinct subunits: 
subunit a (unc B) with amino acid sequence homology 
to yeast mitochondrial ATPase 6, subunit b (unc F) 
with no clearly identifiable sequence homology to any 
of the mitochondrial F, subunits, and subunit c (unc E) 
with striking homology to ATPase 9 or the DCCD- 
inhibitable proteolipid [l-3]. All these three subunits 
are necessary and sufficient for the assembly of a func- 
tional F, proton channel [22,23]. In the case of bovine 
heart mitochondria, preparations of F, with an active 
H+ channel show 8 or more prominent subunits 1241 
some of which have been identified and their role in H ’ 
conductance established. Genetic studies and ex- 
periments using DCCD or oligomycin as inhibitors have 
identified yeast mitochondrial ATPases 6 and 9 as func- 
tional components of the H + channel 125,261. The 
functional role of the 24 kDa subunit (A6L gene pro- 
duct) in H + conduction in heart mitochondrial F, re- 
mains to be established. Recent elegant studies of Joshi 
et al. [27,28] have shown that OSCP and coupling fac- 
tor 6 (Fe) do not function in H + conduction although 
they appear in all mammalian F, preparations. 
Other than subunits 6, 8 and 9, Fn is thus the only 
other protein that has been unambiguously shown to be 
a functional component of bovine heart mitochondrial 
F, by inhibitor as well as reconstitution studies 17-91. 
Since its NHz-terminal 55 amino acid sequence shows 
no homology with the unc operon, Fn may be unique to 
higher organisms, and thus, further sequence analysis 
and elucidation of its role become important. 
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